WHO grants prequalification to GSK's Mosquirix - the first and only approved malaria vaccine

GSK plc (LSE/NYSE: GSK) announced that the World Health Organization (WHO) has awarded prequalification to Mosquirix (also known as RTS,S/AS01), GSK's groundbreaking malaria vaccine. This is the first prequalification for a malaria vaccine and is an important step in rolling out the vaccine in countries with moderate to high P. falciparum malaria transmission.

from Breaking World Pharma News https://ift.tt/N5Tk3UQ